Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The PSSMAR Study (Postacute Sarcopenia, Supplementation With β-hydroxyMethylbutyrate After Resistance Training)

NCT02679742 is registered in ClinicalTrials.gov with Parc de Salut Mar as lead sponsor.

NCT NCT02679742
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02679742 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The PSSMAR Study (Postacute Sarcopenia, Supplementation With β-hydroxyMethylbutyrate After Resistance Training)
Lead sponsor
Parc de Salut Mar
Phase
Not applicable
Overall status
Completed
Start date
March 1, 2017
Completion date
February 6, 2021
Enrollment
32 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sarcopenia